RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Bloom Burton & Co.
B

Bloom Burton & Co. portfolio

Bloom Burton & Co. has 1 portfolio company on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $55M.
Latest deal: Triumvira Immunologics · Aug 1, 2020.
About this page

Its most recent investment on record is Triumvira Immunologics's $55M Series A round in August 2020, alongside Leaps by Bayer, Centre for Commercialization of Cancer Immunotherapy, Oceanpine Capital and 2 others. That company is in Health and bio.

What Bloom Burton & Co. invests in

How Bloom Burton & Co. invests

StageDealsCapital in rounds
Series A 1 100%$55M

Bloom Burton & Co. portfolio companies

CompanyRound with Bloom Burton & Co.Total raisedLatest raise
TTriumvira Immunologics
Health and bio
Series A · $55M$100MMar 17, 2022
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Bloom Burton & Co.. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Bloom Burton & Co., which is a subset of its real portfolio. API: /api/v1/investors/bloom-burton-co (get a free API key). More: the most active VC firms and new venture capital funds.